An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Yurov's Laboratory of Molecular Genetics and Cytogenomics of the Brain, Mental Health Research Center, Moscow, Russia.
2 Laboratory of Molecular Cytogenetics of Neuropsychiatric Diseases, Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University, Moscow, Russia.
1 Yurov's Laboratory of Molecular Genetics and Cytogenomics of the Brain, Mental Health Research Center, Moscow, Russia.
2 Laboratory of Molecular Cytogenetics of Neuropsychiatric Diseases, Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University, Moscow, Russia.
Theoretical model for CIN mediating (A) cancer and (B) neurodegeneration. (A) Genetic defects…
Figure 1
Theoretical model for CIN mediating (A) cancer and (B) neurodegeneration. (A) Genetic defects and genetic-environmental interactions may cause chromosomal/genomic changes, which produce CIN; alternatively, cell populations may adapt to aneuploidy and CIN evolving to a cell population with a fitness advantage. Cells affected by CIN and tolerating deteriorating effects of CIN on cellular homeostasis are able to evolve clonally to produce malignancy. (B) CIN/somatic mosaicism affecting a significant proportion of cells interacting with environmental triggers may result into progressive neuronal cell loss (neurodegeneration) under natural selection pressure and through the programmed cell death (N, normal neurons; CIN, neuronal cell affected by CIN). The model is based on the observations of CIN in the neurodegenerating brain and cancers (Iourov et al., 2009a; Iourov et al., 2009b; Arendt et al., 2010; Granic et al., 2010; Iourov et al., 2011; Jeppesen et al., 2011; Yurov et al., 2011; Driver, 2012; Kennedy et al., 2012; Vijg, 2014; Yurov et al., 2014; Bajic et al., 2015; Heng, 2015; Arendt et al., 2017; Rangel et al., 2017; Caneus et al., 2018; Leija-Salazar et al., 2018; Yurov et al., 2018; Machiela, 2019; Simonetti et al., 2019).
Andriani G. A., Vijg J., Montagna C. (2017). Mechanisms and consequences of aneuploidy and chromosome instability in the aging brain. Mech. Ageing Dev. 161, 19–36. 10.1016/j.mad.2016.03.007
-
DOI
-
PMC
-
PubMed
Arendt T., Brückner M. K., Mosch B., Lösche A. (2010). Selective cell death of hyperploid neurons in Alzheimer’s disease. Am. J. Pathol. 177, 15–20. 10.2353/ajpath.2010.090955
-
DOI
-
PMC
-
PubMed
Arendt T., Stieler J., Ueberham U. (2017). Is sporadic Alzheimer’s disease a developmental disorder? J. Neurochem. 143, 396–408. 10.1111/jnc.14036
-
DOI
-
PubMed
Bajic V., Spremo-Potparevic B., Zivkovic L., Isenovic E. R., Arendt T. (2015). Cohesion and the aneuploid phenotype in Alzheimer’s disease: a tale of genome instability. Neurosci. Biobehav. Rev. 55, 365–374. 10.1016/j.neubiorev.2015.05.010
-
DOI
-
PubMed
Baker D. J., Petersen R. C. (2018). Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. J. Clin. Invest. 128, 1208–1216. 10.1172/JCI95145
-
DOI
-
PMC
-
PubMed